{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20190611",
          "submission_class_code": "REMS",
          "submission_class_code_description": "REMS"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20190510",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20170807",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN",
          "application_docs": [
            {
              "id": "49368",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/205328Orig1s000ltr.pdf",
              "date": "20170815",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20250715",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        }
      ],
      "application_number": "ANDA205328",
      "sponsor_name": "ACTAVIS LABS UT INC",
      "openfda": {
        "application_number": [
          "ANDA205328"
        ],
        "brand_name": [
          "TESTOSTERONE"
        ],
        "generic_name": [
          "TESTOSTERONE"
        ],
        "manufacturer_name": [
          "Actavis Pharma, Inc."
        ],
        "product_ndc": [
          "0591-2114"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "TOPICAL"
        ],
        "substance_name": [
          "TESTOSTERONE"
        ],
        "rxcui": [
          "1599949"
        ],
        "spl_id": [
          "6fb6ef6d-5ed8-4565-916e-30e7b117d612"
        ],
        "spl_set_id": [
          "7227ab2f-c8ef-4bab-92ab-3092182abcc9"
        ],
        "package_ndc": [
          "0591-2114-81"
        ],
        "nui": [
          "N0000175824",
          "N0000000146",
          "M0001109"
        ],
        "pharm_class_epc": [
          "Androgen [EPC]"
        ],
        "pharm_class_moa": [
          "Androgen Receptor Agonists [MoA]"
        ],
        "pharm_class_cs": [
          "Androstanes [CS]"
        ],
        "unii": [
          "3XMK78S47O"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "TESTOSTERONE",
          "active_ingredients": [
            {
              "name": "TESTOSTERONE",
              "strength": "30MG/1.5ML ACTUATION"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SOLUTION, METERED",
          "route": "TRANSDERMAL",
          "marketing_status": "Prescription",
          "te_code": "AT"
        }
      ]
    }
  ]
}